Last reviewed · How we verify
NCT06231940: CDT
Efficacy of Complex Decongestive Therapy (CDT) in Patients With Venous Insufficiency: a Experimental Study
NA trial testing Complex Decongestive Therapy (CDT) in venous insufficiency, in Lymphatic Edema in 21 participants. Completed in 30 September 2024.
30 December 2023
Quick facts
| Lead sponsor | University of Salamanca |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 21 |
| Start date | 1 October 2022 |
| Primary completion | 30 December 2023 |
| Estimated completion | 30 September 2024 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Complex Decongestive Therapy (CDT) in venous insufficiency,
Conditions studied
- Lymphatic Edema — all drugs for Lymphatic Edema →
- Cellulitis of Leg — all drugs for Cellulitis of Leg →
- Vein Disease — all drugs for Vein Disease →
Sponsor
University of Salamanca
Who can join
Adults 35 to 75, any sex, with Lymphatic Edema or Cellulitis of Leg. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study investigates the effectiveness of Complex Decongestive Therapy (CDT) in improving venous flow and reducing symptoms in venous insufficiency patients. The primary goal is to demonstrate CDT's effects, with secondary goals assessing symptom relief, life quality improvement, and adverse effects. The trial is a simple blind randomized design, involving an experimental group receiving CDT plus exercises and a control group doing exercises alone. Participants are adults with specific classifications of venous insufficiency, excluding certain health conditions. The study will involve 12 participants in the experimental group and 9 in the control group.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06231940
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Salamanca trials
Trials by the same sponsor.
- NCT07359495 — Multicomponent Training and Muscle Quality in Older Women · NA · not yet recruiting
- NCT07286539 — Precision Physical Exercise for Personalized Onco-Hematology. · NA · not yet recruiting
- NCT07387770 — Muscle Deterioration in Hospitalized Cancer Patient · NA · not yet recruiting
- NCT07387757 — Exergames in Mental Health · NA · not yet recruiting
- NCT07333768 — EQUISOCK: New Antiequine · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06231940 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Salamanca
- Last refreshed: 7 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06231940.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing